🔥 TRENDING An accident took place at village... ಚರ್ಮಕಾರ ಸಮಾಜ ವಧು-ವರ ಪರಿಚಯ ಮೇಳ ಭಾನುವಾರ... ਤਮਿਲਨਾਡੂ 'ਚ ਵੱਡਾ ਹਾਦਸਾ : 100 ਫੁੱਟ ਡੂੰਘ... ಕನಕದಾಸರ ಜಯಂತಿ ಜಿಲ್ಲೆಯಾದ್ಯಂತ ಅರ್ಥಪೂರ್ಣ... तिलक समारोह के बाद स्कार्पियो में सात... पटवारी के बीच टकराव के माहौल में 38 दि...
20 Nov 2026•
ગુજરાતી मराठी ਪੰਜਾਬੀ বাংলা
BioNTech, Novavax, Moderna Shares Rise on NIH Cancer Vaccine Report
📷 Image: Wikimedia Commons / National Institutes of Health (NIH)
Business

BioNTech, Novavax, Moderna Shares Rise on NIH Cancer Vaccine Report

✍️ Asianet Newsable 🗓 10 Oct 2026, 10:38 AM 👁 895
Share: 💬 WhatsApp 📘 Facebook 𝕏 Post

Shares of BioNTech, Novavax and Moderna led a rally in vaccine stocks after a report indicated the National Institutes of Health is pushing forward with cancer vaccine development.

A news report that the National Institutes of Health is accelerating work on a cancer vaccine sparked investor interest in vaccine makers.
Shares of BioNTech, Novavax and Moderna responded strongly, leading the gains among vaccine-related stocks.
Market analysts said the NIH initiative could open new demand for preventive vaccines, although specifics of the program remain limited.
📲Get App